Total Payments
$324,086
2024 Payments
$25,239
Companies
15
Transactions
479
Medicare Patients
2,791
Medicare Billing
$633,583
Payment Breakdown by Category
Other$243,795 (75.2%)
Consulting$44,132 (13.6%)
Travel$29,044 (9.0%)
Food & Beverage$6,797 (2.1%)
Education$317.45 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $241,275 | 155 | 74.4% |
| Consulting Fee | $44,132 | 21 | 13.6% |
| Travel and Lodging | $29,044 | 171 | 9.0% |
| Food and Beverage | $6,797 | 122 | 2.1% |
| Honoraria | $2,520 | 1 | 0.8% |
| Education | $317.45 | 9 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $298,529 | 441 | $0 (2024) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $12,689 | 12 | $0 (2023) |
| GENZYME CORPORATION | $3,923 | 1 | $0 (2020) |
| Aurinia Pharma U.S., Inc. | $2,869 | 4 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $2,532 | 1 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $1,695 | 2 | $0 (2024) |
| Vertex Pharmaceuticals Incorporated | $516.67 | 1 | $0 (2021) |
| Alexion Pharmaceuticals, Inc. | $470.30 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $364.03 | 4 | $0 (2024) |
| Baxter Healthcare | $165.20 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25,239 | 24 | Otsuka America Pharmaceutical, Inc. ($24,767) |
| 2023 | $69,596 | 74 | Otsuka America Pharmaceutical, Inc. ($59,716) |
| 2022 | $32,692 | 41 | Otsuka America Pharmaceutical, Inc. ($29,038) |
| 2021 | $66,719 | 52 | Otsuka America Pharmaceutical, Inc. ($63,200) |
| 2020 | $28,713 | 55 | Otsuka America Pharmaceutical, Inc. ($24,790) |
| 2019 | $71,879 | 175 | Otsuka America Pharmaceutical, Inc. ($71,754) |
| 2018 | $29,115 | 56 | Otsuka America Pharmaceutical, Inc. ($25,265) |
| 2017 | $132.91 | 2 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($122.20) |
All Payment Transactions
479 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/31/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $45.01 | General |
| 10/25/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.05 | General |
| 10/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 10/02/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 08/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 08/09/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 07/19/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 07/10/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 07/03/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $274.00 | General |
| Category: NEPHROLOGY | ||||||
| 06/05/2024 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $110.20 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 05/24/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 04/24/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,965.00 | General |
| Category: NEPHROLOGY | ||||||
| 04/17/2024 | Mallinckrodt Hospital Products Inc. | TERLIVAZ (Drug) | Food and Beverage | In-kind items and services | $137.63 | General |
| Category: CRITICAL CARE | ||||||
| 03/22/2024 | Baxter Healthcare | Renal - Chronic (Device) | Food and Beverage | In-kind items and services | $100.40 | General |
| Category: Renal | ||||||
| 03/21/2024 | Baxter Healthcare | — | Food and Beverage | In-kind items and services | $64.80 | General |
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,764.00 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | Cash or cash equivalent | $74.00 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | Cash or cash equivalent | $49.97 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | Cash or cash equivalent | $29.48 | General |
| Category: NEPHROLOGY | ||||||
| 02/29/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | Cash or cash equivalent | $23.00 | General |
| Category: NEPHROLOGY | ||||||
| 02/17/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | In-kind items and services | $348.94 | General |
| Category: NEPHROLOGY | ||||||
| 02/15/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | In-kind items and services | $426.20 | General |
| Category: NEPHROLOGY | ||||||
| 02/15/2024 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $92.81 | General |
| Category: NEPHROLOGY | ||||||
| 12/22/2023 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Travel and Lodging | Cash or cash equivalent | $74.00 | General |
| Category: NEPHROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 546 | 4,710 | $485,331 | $138,810 |
| 2022 | 15 | 680 | 4,527 | $541,180 | $162,826 |
| 2021 | 15 | 776 | 4,667 | $541,787 | $165,367 |
| 2020 | 14 | 789 | 12,538 | $657,812 | $166,579 |
Total Patients
2,791
Total Services
26,442
Medicare Billing
$633,583
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2023 | 40 | 201 | $114,369 | $34,645 | 30.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 188 | 238 | $74,256 | $21,724 | 29.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 70 | 182 | $50,050 | $18,420 | 36.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2023 | 11 | 62 | $51,398 | $15,420 | 30.0% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 69 | 220 | $42,680 | $14,714 | 34.5% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 22 | 37 | $30,673 | $9,086 | 29.6% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2023 | 11 | 3,600 | $68,400 | $8,354 | 12.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 39 | 52 | $22,776 | $7,895 | 34.7% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 28 | 29 | $14,819 | $4,189 | 28.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 57 | 63 | $13,986 | $4,080 | 29.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 26 | $1,924 | $283.80 | 14.8% |
| 90962 | Dialysis services, 1 physician visit per month (20 years or older) | Office | 2022 | 44 | 286 | $154,440 | $49,216 | 31.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 198 | 242 | $75,504 | $23,287 | 30.8% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 11 | 80 | $57,040 | $19,607 | 34.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 115 | 322 | $62,468 | $19,503 | 31.2% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 23 | 43 | $30,351 | $10,917 | 36.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 56 | 109 | $29,975 | $9,293 | 31.0% |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 2022 | 19 | 3,200 | $60,800 | $8,114 | 13.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 76 | 90 | $18,387 | $6,460 | 35.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 30 | 36 | $15,120 | $5,082 | 33.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 28 | 29 | $14,819 | $4,898 | 33.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 21 | 22 | $7,656 | $2,450 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $6,240 | $1,647 | 26.4% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 13 | 13 | $3,354 | $1,101 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 14 | 14 | $2,954 | $901.29 | 30.5% |
About Osama Amro, MD., MS
Osama Amro, MD., MS is a Nephrology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2010. The National Provider Identifier (NPI) number assigned to this provider is 1154642643.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Osama Amro, MD., MS has received a total of $324,086 in payments from pharmaceutical and medical device companies, with $25,239 received in 2024. These payments were reported across 479 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($241,275).
As a Medicare-enrolled provider, Amro has provided services to 2,791 Medicare beneficiaries, totaling 26,442 services with total Medicare billing of $633,583. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Seattle, WA
- Active Since 06/18/2010
- Last Updated 04/05/2021
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1154642643
Products in Payments
- JYNARQUE (Drug) $292,722
- TOLVAPTAN (Drug) $5,726
- LUPKYNIS (Drug) $2,869
- Kerendia (Drug) $2,532
- SAMSCA (Drug) $2,026
- LOKELMA (Drug) $224.98
- TERLIVAZ (Drug) $137.63
- FARXIGA (Drug) $125.00
- ULTOMIRIS (Biological) $125.00
- Renal - Chronic (Device) $100.40
- SOLIRIS (Drug) $100.16
- Veltassa (Drug) $58.61
- OXLUMO (Drug) $19.48
- Interventional Products (Device) $10.71
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Seattle
Dr. Ian De Boer, M.d, M.D
Nephrology — Payments: $109,055
Nephrology $109,055
Dr. Peter Nelson, M.d, M.D
Nephrology — Payments: $20,169
Nephrology $20,169
Dr. Anne Pesenson, Md, MD
Nephrology — Payments: $9,580
Nephrology $9,580
Lisa Nakamoto, Md, MD
Nephrology — Payments: $9,179
Nephrology $9,179
Stuart Shankland
Nephrology — Payments: $8,927
Nephrology $8,927
Nelson Goes, M.d, M.D
Nephrology — Payments: $8,840
Nephrology $8,840